Cost-Effectivess Analysis of Brodalumab in Moderate-To-Severe Plaque Psoriasis in Canada

May 1, 2018, 00:00
10.1016/j.jval.2018.04.1634
https://www.valueinhealthjournal.com/article/S1098-3015(18)31940-5/fulltext
Title : Cost-Effectivess Analysis of Brodalumab in Moderate-To-Severe Plaque Psoriasis in Canada
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31940-5&doi=10.1016/j.jval.2018.04.1634
First page :
Section Title :
Open access? : No
Section Order : 852
Categories :
Tags :
Regions :
ViH Article Tags :